Isolation and engineering of antimicrobial peptides targeting pathogenic Escherichia coli and Salmonella of poultry
This study utilizes phage display and next-generation sequencing to isolate and engineer antimicrobial peptides that effectively target pathogenic *Escherichia coli* and *Salmonella* in poultry, demonstrating that combining selected peptides with Cathelicidin-BF and evaluating them in mixed cultures can enhance potency and specificity against these resistant bacteria.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
In the world of farming, chickens are raised in vast numbers to feed the world, but they are also vulnerable to bacterial infections that can spread quickly through a flock. Two of the most troublesome culprits are Escherichia coli and Salmonella, bacteria that can sicken birds and, in some cases, pass to humans. For decades, farmers have relied on antibiotics to keep these infections at bay, but the bacteria are learning to fight back. They are evolving defenses that make standard medicines useless, a problem known as antimicrobial resistance. This resistance is a growing crisis, threatening to leave us with no effective treatments for common infections. Scientists are now searching for new ways to kill these bacteria that do not rely on traditional antibiotics. One promising avenue involves tiny protein fragments called antimicrobial peptides. These are naturally occurring molecules found in many living things, from plants to animals, that act as a first line of defense by punching holes in bacterial cell walls. While nature provides many examples, they are often unstable or difficult to produce in large quantities, so researchers are looking for ways to design better, more effective versions from scratch.
A team of researchers at the University of Nottingham and ADAS set out to find new antimicrobial peptides specifically designed to target the bacteria plaguing poultry. Instead of trying to guess which chemical structures might work, they used a method called phage display, which acts like a massive, automated fishing expedition. They created a library containing billions of tiny viruses, each carrying a unique, random string of sixteen amino acids—the building blocks of proteins—on its surface. They then exposed this library to the target bacteria, E. coli and Salmonella, allowing the viruses to stick to the bacterial surfaces. By washing away the viruses that did not bind and keeping only those that latched on, they could identify which specific strings of amino acids were good at grabbing the bacteria. To make this process even more precise, they used a powerful sequencing technique to read the genetic code of the viruses that survived the wash, pinpointing the exact sequences that were most successful at binding.
From this massive pool of candidates, the researchers narrowed their focus to fifty-seven peptides that showed a strong preference for sticking to the target bacteria. They then tested these fifty-seven candidates to see if they could actually kill the bacteria, not just stick to them. The results were selective but significant: five of the peptides demonstrated the ability to inhibit or kill the bacteria at low concentrations. One peptide, named GWG, stood out because it was effective against all the Gram-negative bacteria tested, while others showed activity only in specific conditions. The researchers also compared these new findings to a known, well-studied peptide called Cathelicidin-BF, which is naturally found in birds and has broad antibacterial properties. They found that while their new peptides were effective, the natural Cathelicidin-BF was even more potent, killing the bacteria at much lower concentrations.
The study took an interesting turn when the researchers looked at how these peptides behaved in mixed environments. In the real world, bacteria rarely exist in isolation; they live in communities with other species. When the researchers tested the peptides in cultures containing both E. coli and Salmonella together, the behavior of the peptides changed. The natural Cathelicidin-BF peptide, which killed both types of bacteria equally well when tested alone, suddenly became much more selective in the mixed culture, preferring to kill E. coli while leaving the Salmonella largely untouched. This shift suggests that the presence of one bacterial species can alter how another species reacts to a treatment, a factor that is often missed when scientists only test bacteria one by one.
To make these peptides even more effective, the team tried a strategy called dimerization, which involves linking two peptide molecules together to form a pair. They created pairs of the new peptides, as well as pairs that combined a new peptide with the natural Cathelicidin-BF. The results showed that joining the molecules changed their properties in surprising ways. In some cases, linking them together made them less effective at stopping bacterial growth, but in other cases, it made them much better at killing the bacteria. For instance, a pair made by linking the new peptide GWG with Cathelicidin-BF retained the ability to selectively kill E. coli in mixed cultures, a trait that was not as pronounced in the single molecules. This suggests that by simply connecting two different peptides, scientists can fine-tune their behavior, potentially creating tools that are more precise or powerful than either piece could be on its own.
The researchers also looked at the safety of these new peptides by testing if they would damage red blood cells, a common concern with antibacterial treatments. Most of the new peptides showed very little harm to blood cells, even at high concentrations. However, one of the new peptides, GWG, did show some ability to damage blood cells, though linking it into a pair reduced this harmful effect. This finding highlights a crucial balance in drug development: the need to kill bacteria without hurting the host. The study concluded that combining the fishing method of phage display with computer tools to predict which sequences might work could speed up the discovery of new treatments. By testing the peptides in mixed bacterial cultures and experimenting with linking them together, the team demonstrated a flexible approach to creating new weapons against resistant bacteria, offering a potential path forward for protecting poultry and, by extension, human health.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.